Thus, if the ability to recognize and present a high range of peptides is coupled with a higher cross-reactive capacity of the HLA-DRB1*15:01 allele compared to other alleles, this could increase the risk of developing autoimmunity, rather than providing effective protection against the virus (112). This evidence concerns the gene HLA-DRB1 and Autoimmunity.